Cureus · 2024 · 10 citations · 5 references
MedicineDermatologyPharmacotherapyDermatopathologyInflammationPain ManagementInflammatory DermatosesInflammatory Disease PharmacotherapyInflammatory LesionsInflammatory Skin DiseasesInflammatory Skin DisordersCellulitis TreatmentJak Inhibitor TherapyJak InhibitorsJanus Kinase Inhibitor TherapyManagement Of CellulitisPustular LesionsScalp InfectionTopical Antimicrobials
Dissecting cellulitis of the scalp (DCS) is a rare condition characterized by painful inflammatory nodules and abscesses on the scalp, often leading to sinus tracts and scarring alopecia. We present a case of DCS in a 26-year-old male who experienced significant clinical improvement following a short course of upadacitinib, a Janus kinase (JAK) inhibitor. The patient received multiple standard treatments such as topical antimicrobials, oral antibiotics, corticosteroids, and intralesional triamcinolone injections, with limited success. However, following the initiation of upadacitinib, the patient reported reduced pain, pustular draining, and bleeding, with significantly improved quality of life. To our knowledge, there is currently a paucity of literature documenting the use of JAK inhibitors for DCS. This case aims to highlight the potential of JAK inhibitors as a therapy for refractory DCS, a condition with limited treatment options.
5
In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)
Julie Parmentier, J W Voss, Candace Graff et al. · BMC Rheumatology · 2018 · 374 citations · Full text
Medicine, Immunology, Pharmacology +16
Afsáneh Alavi, Iltefat Hamzavi, Kurt Brown et al. · British Journal of Dermatology · 2022 · 88 citations · Full text
Emily Kozera, Akshay Flora, John W. Frew · Journal of the American Academy of Dermatology · 2022 · 56 citations